These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17452862)

  • 21. Incidental colonic 18F-fluorodeoxyglucose uptake: do we need colonoscopy for patients with focal uptake confined to the left-sided colon?
    Lee C; Koh SJ; Kim JW; Lee KL; Im JP; Kim SG; Kim JS; Jung HC; Kim BG
    Dig Dis Sci; 2013 Jan; 58(1):229-35. PubMed ID: 22886593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-18 FDG PET/CT demonstration of an adrenal metastasis in a patient with anaplastic thyroid cancer.
    Iagaru A; McDougall IR
    Clin Nucl Med; 2007 Jan; 32(1):13-5. PubMed ID: 17179796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymptomatic familial colon cancer with FDG-PET scanning for recurrent disease.
    Freeman HJ
    Int J Gastrointest Cancer; 2005; 36(3):163-9. PubMed ID: 16720912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging.
    Basu S; Alavi A
    Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical significance of patterns of increased [
    Tsubaki F; Kurata S; Tani J; Sumi A; Fujimoto K; Abe T
    Jpn J Radiol; 2018 Mar; 36(3):181-193. PubMed ID: 29280068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma.
    Petrich T; Börner AR; Otto D; Hofmann M; Knapp WH
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):641-7. PubMed ID: 11976802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidental colonic focal lesions detected by FDG PET/CT.
    Gutman F; Alberini JL; Wartski M; Vilain D; Le Stanc E; Sarandi F; Corone C; Tainturier C; Pecking AP
    AJR Am J Roentgenol; 2005 Aug; 185(2):495-500. PubMed ID: 16037527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid metastasis from primary renal cell cancer on FDG PET/CT.
    Kaushik A; Ho L
    Clin Nucl Med; 2011 Jan; 36(1):56-8. PubMed ID: 21157214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT.
    Lee JC; Hartnett GF; Hughes BG; Ravi Kumar AS
    Nucl Med Commun; 2009 May; 30(5):333-7. PubMed ID: 19262416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
    Choi JW; Yoon YH; Yoon YH; Kim SM; Koo BS
    Ann Surg Oncol; 2011 May; 18(5):1306-11. PubMed ID: 21140231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.
    Shammas A; Degirmenci B; Mountz JM; McCook BM; Branstetter B; Bencherif B; Joyce JM; Carty SE; Kuffner HA; Avril N
    J Nucl Med; 2007 Feb; 48(2):221-6. PubMed ID: 17268018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.
    Robbins RJ; Wan Q; Grewal RK; Reibke R; Gonen M; Strauss HW; Tuttle RM; Drucker W; Larson SM
    J Clin Endocrinol Metab; 2006 Feb; 91(2):498-505. PubMed ID: 16303836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of F-18-fluorodeoxyglucose positron emission tomography in the postoperative evaluation of differentiated thyroid cancer.
    Alzahrani AS; Abouzied ME; Salam SA; Mohamed G; Rifai A; Al Sugair A; Amin T
    Eur J Endocrinol; 2008 May; 158(5):683-9. PubMed ID: 18426827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. F-18 FDG PET/CT imaging of a subcutaneous scalp metastasis from primary carcinoma of the thyroid.
    Niederkohr RD; Dadras SS; Leavitt M; McDougall IR
    Clin Nucl Med; 2007 Feb; 32(2):162-4. PubMed ID: 17242580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.